TAI : 1731.TW

Maywufa Company Ltd.

$20.55 TWD

$0.05 (0.24%)

Volume
54.29K
Average Volume
144.1K
Market Capitalization
$2.73B
P/E Ratio
14.78
Dividend Yield
5.94%
Price Target
Year High
$22.30
Year Low
$20.40
Day High
—
Day Low
—
Payout Ratio
$0.86
Current Ratio
$2.75
Company Overview

TAI

Yue Ju Lai

Household & Personal Products

Consumer Defensive

1731.TW

282

TW

TWD

https://www.maywufa.com.tw

886 2 2713 6621

N/A

N/A

Liquidity Metrics

0.29

2.75

2.12

0.19

0.86

Sales & Valuation

$1.58B

1.69

1.23

11.93

1.72

Profitability

$1.36

$181M

11.50%

14.70%

8.73%

5.61%

P/E Metrics

14.78

1.56

1.56

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

2.70

5/9

$785.93M

$3.31B

$1.09B

$225.04M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Ching-Hui Yu Corporate Governance Officer and Acting Accounting & Financial Officer
Angel Lee Vice Chairman
Yi-Li Lee Vice Chairman
Yu-Ju Lai Director and Manager
Poll Results

No votes yet today — be the first to share your view!

About Maywufa Company Ltd. (TAI:1731.TW) Stock

Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. The company engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale, and retail trading of various beauty products, health products, and sports equipment; retail and wholesale business of health food, such as vitamin pills and oral liquid nutrients; trading, wholesale, and retail of medical drugs and medical equipment; wholesale and retail sales of food, baby products, and general food products; and wholesale trading and agency business. It also provides consulting and analysis; warehousing services; and mother and baby skin care products under the Mustela brand. In addition, the company provides pharmaceuticals ... and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. Maywufa Company Ltd. was incorporated in 1976 and is headquartered in Taipei, Taiwan.

Frequently Asked Questions

What is the current Maywufa Company Ltd. (1731.TW) stock price?

Maywufa Company Ltd.(TAI:1731.TW) stock price is $20.55 in the last trading session. During the trading session, 1731.TW stock reached the peak price of $22.3 while $20.4 was the lowest point it dropped to. The percentage change in 1731.TW stock occurred in the recent session was 0.24% while the dollar amount for the price change in 1731.TW stock was $0.05.

1731.TW's industry and sector of operation?

The TAI listed 1731.TW is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector.

Who are the executives of 1731.TW?

Ching-Hui Yu | Corporate Governance Officer and Acting Accounting & Financial Officer
Angel Lee | Vice Chairman
Yi-Li Lee | Vice Chairman
Yu-Ju Lai | Director and Manager
|

How many employees does 1731.TW have?

Number of 1731.TW employees currently stands at 282. 1731.TW operates from No. 167, Fuxing North Road, Taipei, TPE 105, TW.

Link for 1731.TW official website?

Official Website of 1731.TW is: https://www.maywufa.com.tw

How do I contact 1731.TW?

1731.TW could be contacted at phone #886 2 2713 6621 and can also be accessed through its website. 1731.TW operates from No. 167, Fuxing North Road, Taipei, TPE 105, TW.

How many shares of 1731.TW are traded daily?

The average number of 1731.TW shares traded daily for last 3 months was 144.1K.

What is the market cap of 1731.TW currently?

The market value of 1731.TW currently stands at $2.73B with its latest stock price at $20.55